【摘要】：目的：亨廷頓病(Huntington disease，HD)，是一種以中樞神經(jīng)系統(tǒng)退行性病變?yōu)樘卣鞯某Ｈ旧w顯性遺傳病，目前尚無有效治療方法。人羊膜上皮細(xì)胞（human amniotic epithelial cells，hAECs）具有干細(xì)胞特性和免疫調(diào)節(jié)作用，為治療神經(jīng)退行性變疾病提供了可能。hAECs對(duì)HD動(dòng)物模型病變是否具有修復(fù)作用尚不清楚。本實(shí)驗(yàn)旨在探討hAECs移植治療HD大鼠的療效及其可能的生物學(xué)機(jī)制。 方法：①采用機(jī)械-胰酶消化法分離hAECs，流式細(xì)胞術(shù)（Flow cytometry，F(xiàn)CM）和免疫組織化學(xué)染色檢測表型。②SD大鼠右側(cè)紋狀體注射1μL喹啉酸（quinoline acid，QA）1.8×105μmol/L建立HD模型。成模動(dòng)物隨機(jī)分為模型組(n=16)、培養(yǎng)基對(duì)照組（n=16）和hAECs治療組(n=16)。另設(shè)正常組（n=16）作為平行對(duì)照。hAECs組經(jīng)紋狀體QA損毀側(cè)注射hAECs懸液10μl/只（含6×105個(gè)細(xì)胞），培養(yǎng)基組相同途徑注射等體積無血清L-DMEM培養(yǎng)基。③hAECs移植后第4w和第8w皮下注射阿樸嗎啡誘導(dǎo)旋轉(zhuǎn)，觀察各組大鼠的旋轉(zhuǎn)行為；Morris水迷宮實(shí)驗(yàn)觀察各組大鼠學(xué)習(xí)記憶能力。④HE染色觀察腦組織病理改變。⑤CD68免疫組織化學(xué)染色觀察紋狀體區(qū)小膠質(zhì)細(xì)胞的增生。⑥D(zhuǎn)ARPP-32免疫熒光染色檢測紋狀體區(qū)GABA能神經(jīng)元的損失情況。⑦人細(xì)胞核特異性抗原和神經(jīng)元核蛋白（NeuN）免疫熒光雙染色檢測hAECs存活及分化。⑧FCM檢測hAECs移植后第4w和第8w各組大鼠外周血單個(gè)核細(xì)胞中CD4+IFN-γ+（Th1）、CD4+IL-4+（Th2）、CD4+Foxp3+（Treg）、CD4+IL-17+（Th17）、CD4-CD8+IFN-γ+（CTL1）和CD4-CD8+IL-4+（CTL2）淋巴細(xì)胞亞群百分率的變化。 結(jié)果：①用于治療的第3代hAECs高表達(dá)CD29、CD44、CD49f、CD326、E-cad、CD73，CK19表達(dá)陽性，幾乎不表達(dá)CD34、CD45、CD71、CD80、CD86和HLA-DR。②移植后第4w和第8w，hAECs移植組阿樸嗎啡誘導(dǎo)旋轉(zhuǎn)次數(shù)明顯低于對(duì)照組和模型組(均P0.01)；Morris水迷宮實(shí)驗(yàn)顯示，與模型組相比，hAECs移植后4w的第1d逃避潛伏期明顯縮短(P0.05)。③hAECs組炎癥反應(yīng)較之模型組和培養(yǎng)基組明顯減輕。④與模型組和培養(yǎng)基組比較，hAECs組小膠質(zhì)細(xì)胞（CD68陽性）明顯減少（均P0.01），，而GABA能神經(jīng)元（DARPP-32陽性）顯著增多（均P0.01）。⑤移植后第4w和第8w，病損紋狀體區(qū)可見植入的細(xì)胞存活并表達(dá)NeuN。⑥hAECs移植后外周血Treg細(xì)胞百分比明顯高于對(duì)照組及模型組（均P＜0.05）。 結(jié)論：hAECs移植能明顯改善HD大鼠運(yùn)動(dòng)功能和紋狀體區(qū)病理損傷，其機(jī)制可能與其抑制炎癥反應(yīng)，抑制小膠質(zhì)細(xì)胞增生，保護(hù)GABA能神經(jīng)元有關(guān)。實(shí)驗(yàn)結(jié)果提示，hAECs可能成為臨床HD細(xì)胞治療有價(jià)值的供體細(xì)胞。
[Abstract]:Aim: Huntington's disease (Huntington disease,HD) is an autosomal dominant genetic disease characterized by degenerative lesions of the central nervous system. Human amniotic epithelial cells (human amniotic epithelial cells,hAECs) have the characteristics of stem cells and immunomodulatory effect. It is not clear whether hAECs can repair the pathological changes of HD animal model in the treatment of neurodegenerative diseases. The aim of this study was to investigate the therapeutic effect of hAECs transplantation on HD rats and its possible biological mechanism. Methods: (1) flow cytometry (Flow cytometry,FCM) of hAECs, was isolated by mechanical trypsin digestion method and phenotypes were detected by immunohistochemical staining. (2) HD model was established by injection of 1 渭 L quinolinic acid (quinoline acid,QA) into the right striatum of SD rats. The model animals were randomly divided into three groups: model group (n = 16), medium control group (n = 16) and hAECs group (n = 16). Another normal group (n = 16) was injected with 10 渭 l hAECs suspension (containing 6 脳 10 ~ 5 cells) via striatum QA lesion side in parallel control hAECs group. The rotation was induced by subcutaneous injection of apomorphine at the 4th and 8th week after transplantation, and the rotational behavior of the rats in each group was observed. In the culture medium group, the same volume of serum-free L-DMEM medium was injected in the same way. Morris water maze test was used to observe the learning and memory ability of rats in each group. 4HE staining was used to observe the pathological changes of brain tissue. 5CD68 immunohistochemical staining was used to observe the proliferation of microglia in striatum. 6 DARPP-32 immunofluorescence staining was used to detect the proliferation of microglial cells in striatum. Loss of GABA neurons in striatum. Survival and differentiation of hAECs detected by immunofluorescence double staining of 7 human nuclear specific antigen and nuclear protein (NeuN). Peripheral blood samples of rats at 4th and 8th week after hAECs transplantation were detected by flow cytometry (FCM). CD4 IFN- 緯 (Th1) in blood mononuclear cells, The percentage changes of lymphocyte subsets of CD4 IL-4 (Th2), CD4 Foxp3 (Treg), CD4 IL-17 (Th17), CD4-CD8 IFN- 緯 (CTL1) and CD4-CD8 IL-4 (CTL2) were observed. Results: 1High expression of CD29,CD44,CD49f,CD326,E-cad,CD73,CK19 was found in the third generation of hAECs, but almost no expression of CD34,CD45,CD71,CD80,CD86 and HLA-DR.2 was found at the 4th and 8th week after transplantation. The number of rotation induced by apomorphine in hAECs transplantation group was significantly lower than that in control group and model group (P0.01). The Morris water maze test showed that the escape latency on the 1st day after transplantation of hAECs was significantly shorter than that in the model group (P0.05), and the inflammatory response in the 3hAECs group was significantly less than that in the model group and the culture medium group. 4 compared with the model group and the culture medium group, the inflammatory response of the 3hAECs group was significantly reduced. In hAECs group, the number of microglial cells (CD68 positive) decreased significantly (P0.01), while the number of GABA positive neurons (DARPP-32 positive) increased significantly (P0.01). (5) at the 4th and 8th week after transplantation, the number of microglial cells (DARPP-32 positive) was significantly increased. The percentage of Treg cells in peripheral blood after NeuN.6hAECs transplantation was significantly higher than that in control group and model group (P < 0.05), and the survival rate of implanted cells in striatum was significantly higher than that in control group and model group (P < 0.05). Conclusion: hAECs transplantation can significantly improve motor function and striatum pathological injury in HD rats, and its mechanism may be related to its inhibition of inflammatory response, inhibition of proliferation of microglia and protection of GABA neurons. The results suggest that hAECs may be a valuable donor cell for the treatment of clinical HD cells.
【學(xué)位授予單位】：遵義醫(yī)學(xué)院
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2014
【分類號(hào)】：R742.2

【共引文獻(xiàn)】

相關(guān)期刊論文 前10條

1 劉紅英;DNA芯片技術(shù)在小兒遺傳病中的診斷及應(yīng)用前景[J];國外醫(yī)學(xué)(兒科學(xué)分冊(cè));2002年04期

2 趙育海;Huntington舞蹈病發(fā)病機(jī)制及治療新進(jìn)展[J];國外醫(yī)學(xué).神經(jīng)病學(xué)神經(jīng)外科學(xué)分冊(cè);2001年03期

3 趙育海;Huntington舞蹈病遺傳學(xué)研究進(jìn)展[J];國外醫(yī)學(xué).遺傳學(xué)分冊(cè);2001年06期

4 Xiao-Yong Liu;Jian Chen;Qing Zhou;Jing Wu;Xiao-Ling Zhang;Li Wang;Xiao-Yan Qin;;In vitro tissue engineering of lamellar cornea using human amniotic epithelial cells and rabbit cornea stroma[J];International Journal of Ophthalmology(English Edition);2013年04期

5 李江璇;肖麗玲;;脂肪干細(xì)胞分泌功能的研究進(jìn)展及應(yīng)用前景[J];廣東醫(yī)學(xué);2014年02期

6 崔冬冰;何志旭;李永念;舒莉萍;王黎龍;;人羊膜間充質(zhì)干細(xì)胞的分離與鑒定[J];貴陽醫(yī)學(xué)院學(xué)報(bào);2014年01期

7 李幽蘭;楊川;歐陽麗斯;馬宇昕;賈鈺;陳思;鄔加佳;穆淑花;劉冰冰;雷萬龍;;DHM對(duì)3-NP誘導(dǎo)的PC12細(xì)胞損傷的保護(hù)作用[J];解剖學(xué)研究;2014年01期

8 ;Stem cells and neurodegenerative diseases[J];Science in China(Series C:Life Sciences);2008年04期

9 侯玲玲;洪濤;;干細(xì)胞與神經(jīng)退行性疾病[J];中國科學(xué)(C輯:生命科學(xué));2008年04期

10 梁婧;范金財(cái);蔡國斌;;人羊膜對(duì)創(chuàng)面愈合的促進(jìn)作用[J];中國美容醫(yī)學(xué);2009年01期

相關(guān)博士學(xué)位論文 前10條

1 王育新;亨廷頓病修飾基因的研究及3-硝基丙酸預(yù)處理的神經(jīng)保護(hù)作用[D];天津醫(yī)科大學(xué);2006年

2 李志方;ESCs來源的神經(jīng)前體細(xì)胞移植Aβ?lián)p傷大鼠海馬后的分化與整合[D];第三軍醫(yī)大學(xué);2008年

3 金玲;慢病毒載體介導(dǎo)hTERT基因修飾的人羊膜上皮細(xì)胞重建角膜表層的實(shí)驗(yàn)研究[D];暨南大學(xué);2009年

4 朱慶豐;帕金森病模型大鼠神經(jīng)干細(xì)胞移植基礎(chǔ)研究[D];華東師范大學(xué);2010年

5 張平;BDNF修飾骨髓間充質(zhì)干細(xì)胞治療AD的實(shí)驗(yàn)研究[D];天津醫(yī)科大學(xué);2010年

6 鄭慧芬;自噬在系統(tǒng)性炎癥所致黑質(zhì)多巴胺神經(jīng)元損傷中的作用及機(jī)制研究[D];蘇州大學(xué);2013年

7 劉劍鋒;Exendin-4聯(lián)合脂肪來源干細(xì)胞移植治療急性心梗的作用及機(jī)制研究[D];中國人民解放軍醫(yī)學(xué)院;2013年

8 Elkhalifa Mahjoub Elkhalifa Ahmed;植入羊膜上皮細(xì)胞的化學(xué)去細(xì)胞肌肉組織工程支架對(duì)大鼠脊髓損傷的修復(fù)機(jī)制[D];吉林大學(xué);2013年

9 劉茜;材料調(diào)控脂肪干細(xì)胞命運(yùn)及其血管生成活性的研究[D];清華大學(xué);2012年

10 鄒慶劍;人成纖維細(xì)胞轉(zhuǎn)分化形成神經(jīng)元前體細(xì)胞的研究[D];中國科學(xué)技術(shù)大學(xué);2013年

相關(guān)碩士學(xué)位論文 前10條

1 張念平;應(yīng)用中藥紫河車膜治療硬腦膜缺損[D];山東中醫(yī)藥大學(xué);2010年

2 趙偉瑋;兔角膜內(nèi)皮損傷的組織工程修復(fù)[D];中國海洋大學(xué);2012年

3 劉娟;體外誘導(dǎo)人羊膜細(xì)胞向神經(jīng)細(xì)胞分化[D];遵義醫(yī)學(xué)院;2012年

4 暴志國;ADSCs在組織工程化軟組織當(dāng)中的應(yīng)用與研究[D];鄭州大學(xué);2013年

5 吳元楨;新生樹

本文編號(hào)：2450277